Badger Heart Program: Health screenings targeted to increase cardiovascular awareness in women at four northern sites in Wisconsin

Wisconsin Medical Journal

Volumn 104, Issue 6, 2005, Pages 24-29

  Sanchez, Robert J ^a,b   Khalil, Lisette ^c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DIET; EDUCATION PROGRAM; EXERCISE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HEALTH STATISTICS; HUMAN; INFORMATION PROCESSING; MASS SCREENING; MEDICAL EDUCATION; RISK ASSESSMENT; SMOKING CESSATION; HEALTH PROMOTION; LIFESTYLE; MIDDLE AGED; RISK FACTOR; RURAL POPULATION; UNITED STATES; WOMEN'S HEALTH;

AWARENESS; CARDIOVASCULAR DISEASES; FEMALE; HEALTH PROMOTION; HUMANS; LIFE STYLE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; RURAL POPULATION; WISCONSIN; WOMEN'S HEALTH;

EID: 27744560564     PISSN: 10981861     EISSN: 10981861     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. Available at: www.americanheart.org/downloadable/heart/ 1075102824882HDSStats2004UpdateREV1-23-04.pdf Accessed July 7, 2005.
2. US Centers for Disease Control, National Center for Health Statistics. Mortality Trends. Available at: http://www.cdc.gov/nchs/data/series/sr_03/ sr03_001acc.pdf. Accessed July 30, 2005.
3. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy post-menopausal women, principal results from the Women's Health Initiative randomized controlled trial, writing group for the Women's Health Initiative investigators. JAMA. 2002;288:321-333.
4. Manson JE, Jsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. Women's Health Initiative investigators. N Engl J Med. 2003;349:523-534.
5. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) research group. JAMA. 1998;280:605-613.
6. Mosca L, Jones WK, Kind KB, et al. American Heart Association Women's Heart Disease and Stroke Campaign Task Force: awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Arch Fam Med. 2000;9:506-515.
7. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease. Circulation. 2004;109:573-579.
8. Mosca L, Appel LJ, Benjamin EJ, Berra K, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
9. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality, a meta analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
10. Greenlund KJ, Zheng ZJ, Keenan NL, et al. Trends in self-reported multiple cardiovascular disease risk factors among adults in the united states, 1991-1999. Arch Intern Med. 2004;164:181-188.
11. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastain in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
12. Downs JR, Clearfield M, Weis S, et al. AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998;279:1615-1622.
13. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atrovastain in the Anglo Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicenter randomized controlled trial. Lancet. 2003;361:1149-1158.
14. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.
15. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohort of young adult and middle-aged men and women. JAMA. 1999;282:2012-2018
16. Yusuf HF, Giles WH, Croft JB, et al. Impact of multiple risk facgtor profiles on determining cardiovascular disease risk. Prev Med. 1998;27:1-9.
17. Daviguls ML, Liu K, Greenland P, et al. Benefit of a favorable cardiovascular risk-factor profiles in middle age with respect to Medicare cost. N Engl J Med. 1998;339:1122-1129.